Exchange: OTC·Updated 02:22 PM EDT

NSTM Novelstem International Corp

$0.0095
$0.0011
(10.38%)
Today
Mkt Cap$468,658.00
Vol1,000.00

About NSTM

NovelStem International Corp. develops novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company was founded by Mitchell Rubenstein and Laurie S. Silvers on January 22, 1993 and is headquartered in Parkland, FL.
50

Neutral Sentiment

How do you feel about NSTM?

Advertisement|Remove ads.